Gilead Sciences Inc
NASDAQ: GILD
$83.99
+$0.05 (+0.1%)
Closing Price on September 23, 2024
GILD Articles
U.S. equity markets opened higher this morning, but struggled to stay in positive territory for most of the morning. There was little economic data released today. In Asia, Hong Kong’s consumer...
Published:
Last Updated:
U.S. equity markets opened lower this morning following a downturn in Europe and mixed markets in Asia. Data releases were limited everywhere today as well. In Asia, a weaker yen boosted the Nikkei,...
Published:
Last Updated:
Jon OggInvestors and traders are always on the lookout for fresh research ideas from Wall St. that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research calls to find...
Published:
Last Updated:
U.S. equity markets opened lower this morning following a stack of poor reports on the Italian economy. New industrial orders were down, industrial sales were down, and retail sales were down. To top...
Published:
Last Updated:
Typically, large Wall St. firms suggest a broad asset allocation portfolio for their clients. Within the portfolio, they use a designated weighting for each stock that makes the cut. For the...
Published:
Last Updated:
Jon OggThese are some of this Thursday’s top analyst upgrades, downgrades and initiations seen from select Wall St. research calls. Amazon.com Inc. (NASDAQ: AMZN) cut to Neutral from Overweight at...
Published:
Last Updated:
For anybody that has missed the big stock market rally, it can be very disheartening to watch as anchors on every business and news channel talk about indices hitting all-time highs day after day....
Published:
Last Updated:
Thinkstock24/7 Wall St. is taking a daily aim at the world exchange-traded funds (ETFs). Many are great, and many are actively traded and truly represent what investors are trying to get exposure to....
Published:
Last Updated:
Thinkstock24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or fall regardless of the market direction, and the sector...
Published:
Jon OggThese are some of this Monday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Abaxis Inc. (NASDAQ: ABAX) cut to Underperform from Neutral. Activision...
Published:
Jon OggThese are some of this Monday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Apache Corp. (NYSE: APA) cut to Neutral at Macquarie. Bank of America...
Published:
ThinkstockBig biotech had a stellar 2012. In 2013, though, the large biotech companies may be dwarfed in performance by the smaller players in the $1 billion to $5 billion range. If you look at the...
Published:
Last Updated:
Jon OggThe largest biotech stocks have been great performers in 2012. The question is whether that can be sustained in 2013. If Wall St. analysts are correct, biotech and biohealth investors are...
Published:
Last Updated:
Thinkstock24/7 Wall St. is looking for the next great biotech stocks for 2013 after great gains have been seen in 2012. If you look at the consensus price targets from analysts for the coming 12...
Published:
Last Updated:
ThinkstockInsider selling is starting to get massive before year-end when higher capital gains taxes will kick in. We continue to expect that corporate insiders, venture backers, private equity...
Published:
Last Updated: